BeStock  
Stocks › HAE

Haemonetics HAE

US equityMarket cap rank #2142
$104.68 +$0.00 (0.00%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $104.68 0.00%
Open$104.29
Prev close$104.68
Day range$103.65 – $106.26
Volume652.6K
Market cap$4.76B
P/E (TTM)50.6
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Mar 2026

Revenue$1.33B-2.0% YoY
Operating profit$241.40M+20.0% YoY
Net profit$97.31M-42.0% YoY
Diluted EPS$2.05-38.1% YoY

Annual revenue

$870.5MFY21$993.2MFY22$1.2BFY23$1.3BFY24$1.4BFY25$1.3BFY26

Profitability & balance sheet

Gross margin59.0%
Operating margin18.1%
Net margin7.1%
Return on equity11.2%
Return on assets4.0%
Return on invested capital5.7%
Current ratio3.08
Liabilities / assets64.6%
Cash & investments$223.38M
Total debt$1.17B
Net cash (debt)-$950.77M
Free cash flow / sales21.5%

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Apheresis$191.32M 56.4%
  • MedSurg$148.06M 43.6%

Balance sheet

Line item 2027 Q1 2026 Q4 2026 Q3 2026 Q2 2026 Q1
Total Assets $2.37B $2.40B $2.49B $2.44B $2.46B
Total Current Assets $810.83M $834.88M $943.67M $899.68M $913.16M
Cash and Cash Equivalents & Short-Term Investments $223.38M $245.44M $363.37M $296.43M $292.90M
-Cash and Cash Equivalents $223.38M $245.44M $363.37M $296.43M $292.90M
Receivables $216.07M $216.86M $195.71M $207.07M $200.75M
-Accounts Receivable $216.07M $216.86M $195.71M $207.07M $200.75M
Inventory $306.74M $306.37M $321.19M $336.21M $360.53M
Other Current Assets $64.64M $66.21M $63.42M $59.98M $58.98M
Total Non-Current Assets $1.55B $1.56B $1.55B $1.54B $1.55B
Net PPE $303.78M $305.76M $297.23M $292.48M $286.87M
-Gross PPE $854.27M $841.83M $836.81M $815.31M $795.10M
-Accumulated Depreciation -$550.49M -$536.07M -$539.58M -$522.83M -$508.23M
Goodwill and Other Intangible Assets $1.09B $1.10B $1.03B $1.03B $1.06B
-Goodwill $656.88M $656.37M $606.83M $606.10M $607.30M
-Other Intangible Assets $434.51M $447.66M $419.73M $428.36M $450.63M
Non-Current Deferred Assets $9.43M $9.52M $7.33M $7.57M $7.84M
Other Non-Current Assets $149.96M $141.74M $216.09M $207.97M $196.29M
Total Liabilities $1.53B $1.60B $1.58B $1.59B $1.58B
Total Current Liabilities $263.24M $282.60M $539.87M $548.32M $531.41M
Payables $56.34M $51.06M $48.69M $61.69M $46.01M
-Accounts Payable $56.34M $51.06M $48.69M $61.69M $46.01M
Current Accrued Expenses $38.15M $68.19M $52.10M $48.27M $35.81M
Short-Term Debt and Capital Lease Obligation $4.96M $5.02M $304.75M $304.34M $303.95M
-Current Debt $4.96M $5.02M $304.75M $304.34M $303.95M
Other Current Liabilities $163.80M $116.03M $134.33M $134.02M $145.64M
Total Non-Current Liabilities $1.27B $1.32B $1.04B $1.04B $1.05B
Long Term Debt and Capital Lease Obligation $1.17B $1.22B $919.99M $920.39M $920.83M
-Long Term Debt $1.17B $1.22B $919.99M $920.39M $920.83M
Non-Current Deferred Liabilities $38.69M $38.05M $55.98M $58.20M $59.49M
Other Non-Current Liabilities $57.17M $59.39M $63.61M $66.07M $68.07M
Total Equity $837.10M $796.32M $911.45M $849.17M $882.30M
Stockholders' Equity $837.10M $796.32M $911.45M $849.17M $882.30M
Capital Stock $455,000.00 $453,000.00 $468,000.00 $467,000.00 $482,000.00
-Common Stock $455,000.00 $453,000.00 $468,000.00 $467,000.00 $482,000.00
Additional Paid-In Capital $566.76M $554.14M $564.50M $552.91M $562.01M
Retained Earnings $311.52M $279.34M $381.09M $336.32M $356.05M
Gains/Losses Not Affecting Retained Earnings -$41.63M -$37.61M -$34.61M -$40.53M -$36.24M
Current Deferred Liabilities – $42.31M – – –

Income statement

Line item 2026 ANNUAL 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL
Total Revenue as Reported $1.33B $1.36B $1.31B $1.17B $993.20M
Total Operating Revenue $1.33B $1.36B $1.31B $1.17B $993.20M
Cost of Revenue $546.44M $611.87M $617.51M $553.56M $487.69M
Gross Profit $787.59M $748.96M $691.55M $615.10M $505.50M
Operating Expense $546.19M $547.77M $516.25M $459.45M $434.36M
Selling and Admin Expenses $442.42M $436.79M $429.78M $376.68M $340.14M
Research & Development $59.77M $62.72M $54.44M $50.13M $46.80M
Depreciation & Amortization & Depletion $44.00M $48.26M $32.03M $32.64M $47.41M
-Depreciation & Amortization $44.00M $48.26M $32.03M $32.64M $47.41M
Operating Profit $241.40M $201.19M $175.30M $155.65M $71.15M
Net Non-Operating Interest Income (Expense) -$28.70M -$9.75M -$13.02M -$14.63M -$17.12M
Non-Operating Interest Expense $28.70M $9.75M $13.02M $14.63M $17.12M
Other Income (Expense) -$84.67M $20.63M -$10.42M $382,000.00 $9.60M
Special Income (Charges) -$84.67M $20.63M -$10.42M $382,000.00 $9.60M
-Less:Restructuring and Mergern & Acquisition -$1.88M -$23.02M $0.00 $0.00 –
-Less:Impairment of Capital Assets $86.55M $2.39M $10.42M $0.00 $0.00
Pretax Profit $128.03M $212.07M $151.87M $141.40M $63.63M
Tax $30.72M $44.39M $34.31M $26.00M $20.25M
Net Profit $97.31M $167.68M $117.56M $115.40M $43.38M
Profit from Continuing Operations $97.31M $167.68M $117.56M $115.40M $43.38M
Net Income to Parent Company $97.31M $167.68M $117.56M $115.40M $43.38M
Net Income to Common Stockholders $97.31M $167.68M $117.56M $115.40M $43.38M
Basic EPS $2.06 $3.33 $2.32 $2.27 $0.85
Diluted EPS $2.05 $3.31 $2.29 $2.24 $0.84
-Gain on Sale Of Business – – – $382,000.00 $9.60M

Discussion

No comments yet — be the first to weigh in on HAE.

Leave a comment

Scroll to Top